Adolescent Oxycodone Exposure on Oxycodone Reinforcement and Reward Neurocircuitry in Adulthood

青少年羟考酮暴露对成年期羟考酮强化和奖励神经回路的影响

基本信息

项目摘要

ABSTRACT: Adolescence is one of the most vulnerable stages for the long-term effects of drugs of abuse and an estimated 3.4 million from adolescence have misused prescription opioids in the past year, with 3.5% of them being in early/mid stage of adolescents (12 -17 years old) and 7.1% of them being in the late adolescence to emerging adulthood stage (ages 18-25) (Substance Abuse and Mental Health Services Administration, 2017). Early adolescent initiation of prescriptions opioids is more likely to result in subsequent prescription opioid misuse in adulthood than late adolescent initiation (McCabe et al., 2007). Therefore, there is a need to better understand the long-term neurobiological consequences that misuse of prescription opioids in early/mid and late adolescence may have in adulthood in order to develop unique interventions. Oxycodone is one of the most commonly misused prescription opioids among adolescents. However, there is a substantial gap in knowledge about the long-term neurobiological consequences of adolescence exposure to oxycodone on reward-related behaviors in adulthood. The use of pre-clinical animal models can help to understand the effects of adolescent exposure to oxycodone on adult mesolimbic reward pathway. The major goal of this small grant project (R03) is to obtain proof of concept data to show that adolescent oxycodone exposure leads to a persistent increase in reinforcing properties/dopamine release in adulthood. Therefore, the overall objectives are to determine the effects of early and late adolescence exposure to oxycodone on drug reinforcement and dopamine release in nucleus accumbens in adulthood and assess if there are differential effects between early and late adolescence exposure. Since the early and late adolescence drug exposure will have differential effects on the neurobiology of reward circuits due to hormonal changes (Spears, 2000; 2015), we will utilize two time-points of adolescence exposure. This proposal will utilize state-of-the-art procedures to elucidate how adolescence exposure alters reinforcing properties of oxycodone within the mesolimbic dopamine system. This is a highly significant project that will provide first data on how adolescent exposure to oxycodone will have long-lasting effects on VTA rewarding properties in adulthood. Once we establish this phenomenon in this model, the data will be used to further understand the persistent changes in reward circuitry and molecular mechanisms in future R01 application.
摘要: 青少年是最容易受到滥用药物长期影响的阶段之一, 3.4在过去的一年里,有100万青少年滥用处方阿片类药物,其中3.5%在 青少年(12 - 17岁)的早期/中期和7.1%的人处于青春期后期至出现 成年阶段(18-25岁)(药物滥用和精神卫生服务管理局,2017年)。早期 青少年开始处方阿片类药物更可能导致随后的处方阿片类药物滥用, 成年期比青少年后期开始(McCabe等人,2007年)。因此,有必要更好地了解 早期/中期和晚期滥用处方阿片类药物的长期神经生物学后果 青少年在成年期可能会采取的措施,以便制定独特的干预措施。羟考酮是目前 青少年中经常滥用处方阿片类药物。然而,在知识方面存在着巨大的差距, 青少年暴露于羟考酮对奖励相关的长期神经生物学后果 成年后的行为。使用临床前动物模型可以帮助了解青少年的影响, 暴露于羟考酮对成年中脑边缘奖赏通路的影响。本小额赠款项目的主要目标(R 03) 是获得概念验证数据,以表明青少年羟考酮暴露导致持续增加 在成年期加强多巴胺的释放。因此,总体目标是确定 青少年早期和晚期暴露于羟考酮对药物强化和多巴胺释放的影响 在成年期的脑桥核,并评估是否有早期和晚期之间的差异效应 青春期暴露。由于青春期早期和晚期的药物暴露将有不同的影响, 由于荷尔蒙变化(Spears,2000; 2015),我们将利用两个时间点 青春期暴露。这项提案将利用最先进的程序来阐明青春期是如何 暴露改变了羟考酮在中脑边缘多巴胺系统内的强化性质。这是一个高度 重要的项目,将提供关于青少年接触羟考酮将如何产生长期影响的第一批数据。 对成年后VTA奖励特性的影响。一旦我们在这个模型中建立了这种现象, 将被用于进一步了解奖励电路和分子机制的持续变化, 未来的R 01应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sheketha Renay Hauser其他文献

Sheketha Renay Hauser的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sheketha Renay Hauser', 18)}}的其他基金

Serotonin-7 receptors and Alcohol-seeking Behaviors
5-羟色胺-7 受体和饮酒行为
  • 批准号:
    10659697
  • 财政年份:
    2023
  • 资助金额:
    $ 7.93万
  • 项目类别:
Adolescent Oxycodone Exposure on Oxycodone Reinforcement and Reward Neurocircuitry in Adulthood
青少年羟考酮暴露对成年期羟考酮强化和奖励神经回路的影响
  • 批准号:
    10447174
  • 财政年份:
    2021
  • 资助金额:
    $ 7.93万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了